XTX Topco’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-147,946
Closed -$12.6M 4201
2026
Q1
$12.6M Buy
+147,946
New +$13.2M 0.22% 32
2025
Q4
Sell
-19,150
Closed -$1.53M 3370
2025
Q3
$1.53M Buy
+19,150
New +$1.63M 0.08% 320
2025
Q2
Sell
-6,467
Closed -$606K 2449
2025
Q1
$606K Buy
+6,467
New +$579K 0.03% 883
2024
Q4
Sell
-10,137
Closed -$1.05M 2366
2024
Q3
$1.05M Buy
10,137
+5,776
+132% +$589K 0.08% 400
2024
Q2
$423K Buy
+4,361
New +$402K 0.04% 746
2023
Q1
Sell
-14,103
Closed -$1.11M 1319
2022
Q4
$1.11M Sell
14,103
-828
-6% -$62.1K 0.24% 68
2022
Q3
$1.05M Buy
14,931
+2,495
+20% +$196K 0.26% 42
2022
Q2
$997K Buy
+12,436
New +$972K 0.41% 28
2021
Q4
Sell
-2,652
Closed -$200K 724
2021
Q3
$200K Buy
+2,652
New +$211K 0.07% 512

Other funds holding CL

XTX Topco's CL Position: Q2 2026 in Review

XTX Topco sold out of Colgate-Palmolive (CL) in Q2 2026, closing a stake of 147,946 shares — an estimated $12.6M sold.

XTX Topco first reported a position in CL in Q3 2021 and held it in 9 quarters. The position peaked at $12.6M in Q1 2026. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • XTX Topco reported no remaining Colgate-Palmolive position as of Q2 2026 after selling out during the quarter.
  • XTX Topco sold 147,946 Colgate-Palmolive shares in Q2 2026, an estimated $12.6M.
  • XTX Topco first reported a position in Colgate-Palmolive in Q3 2021 and held it in 9 quarters.
  • XTX Topco's Colgate-Palmolive position peaked at $12.6M in Q1 2026.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.